Clinical Research Directory
Browse clinical research sites, groups, and studies.
HEME Home Transfusion Program
Sponsor: Dana-Farber Cancer Institute
Summary
This research study is evaluating whether a new care delivery program that provides access to home blood transfusions in hospice (i.e, HEME-Hospice) compared to regular standard of care improves quality of life, mood, and end-of-life health care utilization for patients with hematologic malignancies.
Official title: Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
700
Start Date
2025-09-10
Completion Date
2029-05-31
Last Updated
2025-09-17
Healthy Volunteers
No
Conditions
Interventions
HEME-Hospice Program
A care delivery program that combines home-based transfusions with routine home hospice care. Transfusions are administered by trained transfusion nurses. Standard hospice care is provided by an interdisciplinary team of non-transfusion nurse case managers, hospice aides, social workers, and chaplains.
Locations (2)
Brigham and Women's Hospital
Boston, Massachusetts, United States
Dana-Farber Cancer Institute
Boston, Massachusetts, United States